Roche to pay $7.1 bn for Telavant Holdings
Swiss pharmaceutical group Roche said Monday it will pay $7.1 billion to buy Telavant Holdings, a group developing new treatments for inflammatory bowel diseases.
Oct 23, 2023
0
0
Swiss pharmaceutical group Roche said Monday it will pay $7.1 billion to buy Telavant Holdings, a group developing new treatments for inflammatory bowel diseases.
Oct 23, 2023
0
0
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract categorized into ulcerative colitis and Crohn's disease. Currently, aminosalicylates, glucocorticoids, immunomodulating drugs, ...
Oct 20, 2023
0
0
Immersive virtual reality—digital technology that allows a person to experience being physically present in a non-physical world—seems to ease the pain and distress felt by patients with cancer, suggests a pooled data ...
Oct 16, 2023
0
9
Understanding how damaged organs heal themselves is important for scientists trying to develop treatments that regenerate injured, diseased, or aged tissue.
Oct 11, 2023
0
55
Everyone has a different tolerance for spicy food—some love the burn, while others can't take the heat. But the scientific consensus on whether spicy food can have an effect—positive or negative—on your health is pretty ...
Oct 10, 2023
0
18
A research team from MedUni Vienna has now demonstrated for the first time the central role of macrophages in the renewal of intestinal cells, which sheds light on the complex interplay between immune cells and tissue regeneration. ...
Oct 10, 2023
0
71
An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical ...
Oct 3, 2023
0
43
Inflammatory bowel disease (IBD) is strongly associated with gout, according to a study published online Sept. 1 in JGH Open.
Oct 3, 2023
0
0
Australian researchers at Walter and Eliza Hall Institute (WEHI) have found that a genetic change that increases the risk of inflammation, through a process described as "explosive" cell death, is carried by up to 3% of the ...
Oct 3, 2023
0
16
An immune factor released by white blood cells during infection or inflammation works to suppress the body's immune response instead of enhancing it, according to Mater researchers.
Sep 29, 2023
0
1